Journal articles on yoga therapy increase 3-fold in last 10 years

During the last 10 years, the number of articles in peer-reviewed journals worldwide about clinical trials of yoga therapy to alleviate disease-related symptoms increased 3-fold. This large-scale analysis of published research studies spanning 46 years, 29 countries, and more than 28,000 study participants is published in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine website until September 17, 2015.

Pamela Jeter, PhD, Johns Hopkins University (Baltimore, MD) and Maryland University of Integrative Health (Laurel, MD), Sat Bir Khalsa, PhD, Harvard Medical School (Boston, MA), and coauthors found that yoga therapy was most often used for the treatment of mental health, cardiovascular disease, and respiratory disease. They report their findings in the article "Yoga as a Therapeutic Intervention: A Bibliometric Analysis of Published Research Studies from 1967 to 2013." This study was supported in part by the Patanjali Yogpeeth Trust (PYP USA).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exercise temporarily improves muscle insulin resistance linked to genetic risk for type 2 diabetes